date,title,source
Oct-17-18,"Analysis: Positioning to Benefit within Matrix Service, Mersana Therapeutics, Quorum Health, Canopy Growth, Bristow Group, and Menlo Therapeutics  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-06-18,Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2018 Financial Results and Business Updates,GlobeNewswire
Nov-08-18,Mersana Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference,GlobeNewswire
Nov-08-18,Mersana Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference,GlobeNewswire
Nov-12-18,"Mersana Therapeutics Presents Pre-clinical Data at AACR-NCI-EORTC on Two Additional, Proprietary Antibody Drug Conjugate Platforms and a Pre-clinical Update for XMT-1522 in Non-small Cell Lung Cancer",GlobeNewswire
Nov-12-18,"Mersana Scientists Present Updates on XMT-1522, XMT-1536 and the Dolaflexin Platform at World ADC 2018",GlobeNewswire
Nov-13-18,Mersana Therapeutics Announces Third Quarter 2018 Financial Results and Provides Business Updates,GlobeNewswire
Nov-27-18,"Mersana Therapeutics Appoints Dirk Huebner, M.D., as Chief Medical Officer",GlobeNewswire
Nov-28-18,"New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Jan-02-19,Mersana Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-04-19,"Are Mersana Therapeutics, Inc.s (NASDAQ:MRSN) Interest Costs Too High?",Simply Wall St.
Jan-04-19,Mersana to discontinue development of one cancer treatment to focus on another,MarketWatch
Jan-04-19,Mersana Therapeutics Announces Strategic Priorities and Goals for 2019 and Beyond,GlobeNewswire
Jan-10-19,Mersana CEO details path forward after breakup with Takeda,American City Business Journals
Feb-20-19,Mersana Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Feb-28-19,Mersana Therapeutics Announces Proposed Public Offering of Common Stock,GlobeNewswire
Mar-01-19,Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2018 Financial Results and Business Updates,GlobeNewswire
Mar-01-19,"The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis",Benzinga
Mar-01-19,Mersana Therapeutics Announces Pricing of Public Offering of Common Stock,GlobeNewswire
Mar-05-19,Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares,GlobeNewswire
